EyePoint Pharmaceuticals, Inc.·4/A

Jun 22, 4:00 PM ET

Ross Leonard S 4/A

4/A · EyePoint Pharmaceuticals, Inc. · Filed Jun 22, 2018

Insider Transaction Report

Form 4/AAmended
Period: 2018-06-14
Ross Leonard S
Corporate Controller
Transactions
  • Award

    Restricted Stock Units

    2018-06-14+24,84024,840 total
    Common Stock (24,840 underlying)
  • Award

    Stock Option (right to buy)

    2018-06-14+99,36099,360 total
    Exercise: $2.04Exp: 2028-06-14Common Stock (99,360 underlying)
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
  • [F2]The restricted stock units will vest in three equal annual installments beginning June 14, 2019. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
  • [F3]The option to purchase will vest and become exercisable in three equal annual installments beginning June 14, 2019.

Documents

1 file
  • 4
    doc4a.xml

    FORM 4/A SUBMISSION